Autoimmune Diseases  >>  Avonex (recombinant IFN-β-1a)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avonex (recombinant IFN-β-1a) / Biogen
NCT01863069: Avonex®: Safety, Blood Levels and Effects

Completed
1
77
Europe
Interferon beta 1a, AVONEX, (IM) AVONEX®
Trio Medicines Ltd., Biogen
Multiple Sclerosis (MS)
10/01
10/01
NCT00913250: A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

Completed
1
96
US
Serum containing Avonex, Avonex, Serum Free Avonex
Biogen
Multiple Sclerosis
 
10/03
NCT01500408: Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers

Completed
1
110
US
Interferon beta-1a (current approved manufacturing process invloving FBS), Avonex®), Interferon beta-1a (new process, manufactured without FBS)
Biogen
Multiple Sclerosis
04/12
04/12

Download Options